However, single-cell sequencing data analysis indicated that the capture of immune cells in gastric tumour tissue is low, which means that relying on the marker genes of immune cells, EFNA4, and ETS1 to construct prognostic models will result in significant errors when evaluating the prognosis of patients with GC. This evidence concerns the gene EFNA4 and gastric cancer.